Differential diagnosis of renal tumors with papillary architecture

Advances in Anatomic Pathology

Volumn 18, Issue 2, 2011, Pages 120-132

  Tickoo, Satish K ^a   Reuter, Victor E ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

kidney; papillary architecture; papillary renal cell carcinoma; renal cell carcinoma

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR;

CLEAR CELL CARCINOMA; CYTOARCHITECTURE; DIFFERENTIAL DIAGNOSIS; EPITHELIUM TUMOR; GENETIC DISORDER; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; LEIOMYOMATOSIS; MEDULLARY CARCINOMA; MUCINOUS CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; REVIEW; SPINDLE CELL CARCINOMA; TUMOR GROWTH;

ALGORITHMS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KIDNEY NEOPLASMS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 79952128481     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e31820cb3dd     Document Type: Review

References (88)

1. Reuter VE, Tickoo SK. Adult renal tumors. In: Mills SE, ed. Sternberg's Diagnostic Surgical Pathology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2009:1757-1798.
2. Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol. 2002;26:281-291. (Pubitemid 34184451)
3. Reuter VE, Presti JC Jr. Contemporary approach to the classification of renal epithelial tumors. Semin Oncol. 2000;27: 124-137. (Pubitemid 30205368)
4. Tickoo SK, Reuter VE. Kidney tumors and tumor-like conditions. In: Amin MB, McKenney JK, Tickoo SK, et al, eds. Diagnostic Pathology: Genitourinary. Amirsys Publishing, Inc; 2010:1-2-1-242.
5. Delahunt B, Eble JN. Papillary renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004:27-29.
6. Tickoo SK, Argani P, Amin MB. Tumors of the kidney. In: Zou XJ, Laszik Z, Nadasdy T, et al, eds. Silva's Diagnostic Renal Pathology. NY: Cambridge University Press; 2009: 568-602.
7. Amin MB, Corless CL, Renshaw AA, et al. Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol. 1997;21:621-635. (Pubitemid 27265749)
8. Klatte T, Wunderlich H, Patard JJ, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: An international multicentre experience. BJU Int. 2007;100:21-25. (Pubitemid 46878555)
9. Delahunt B, Eble JN. Papillary renal cell carcinoma: A clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537-544. (Pubitemid 27293491)
10. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol. 1995; 19:842-849.
11. Renshaw AA, Zhang H, Corless CL, et al. Solid variants of papillary (chromophil) renal cell carcinoma: Clinicopathologic and genetic features. Am J Surg Pathol. 1997;21: 1203-1209. (Pubitemid 27422320)
12. Kunju LP, Wojno K, Wolf JS Jr, et al. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: Expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical and molecular features. Hum Pathol. 2008;39:96-101. (Pubitemid 350216165)
13. Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32: 590-595. (Pubitemid 32601240)
14. Tickoo SK, Reuter VE. Subtyping papillary renal cell carcinoma: A clinicopathologic study of 103 cases. Mod Pathol. 2001;14:124A.
15. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624. (Pubitemid 36514472)
16. Sika-Paotonu D, Bethwaite PB, McCredie MR, et al. Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol. 2006;30: 1091-1096. (Pubitemid 44299341)
17. Okoń K, Siń czak-Kuta A, Stachura J. Renal papillary carcinoma classification into subtypes may be reproduced by nuclear morphometry. Anal Quant Cytol Histol. 2009;31: 109-117.
18. Lager DJ, Huston BJ, Timmerman TG, et al. Papillary renal tumors. Morphologic, cytochemical, and genotypic features. Cancer. 1995;76:669-673.
19. Linehan WM. Genetic basis of bilateral renal cancer: Implications for evaluation and management. J Clin Oncol. 2009;27:3731-3733.
20. Klatte T, Pantuck AJ, Said JW, et al. Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res. 2009;15:1162-1169.
21. Sanders ME, Mick R, Tomaszewski JE, et al. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol. 2002;161: 997-1005. (Pubitemid 34988387)
22. Yang XJ, Tan MH, Kim HL, et al. A molecular classification of papillary renal cell carcinoma. Cancer Res. 2005;65:5628-5637. (Pubitemid 40911163)
23. Schmidt L, Junker K, Nakaigawa N, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene. 1999;18:2343-2350. (Pubitemid 29192711)
24. Teloken PE, Thompson RH, Tickoo SK, et al. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. J Urol. 2009;182:2132-2136.
25. Margulis V, Tamboli P, Matin SF, et al. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer. 2008;112:1480-1488. (Pubitemid 351441160)
26. Schrader AJ, Rauer-Bruening S, Olbert PJ, et al. Incidence and long-term prognosis of papillary renal cell carcinoma. J Cancer Res Clin Oncol. 2009;13:799-805.
27. Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10:1131-1141. (Pubitemid 17205211)
28. Kennedy SM, Merino MJ, Linehan WM, et al. Collecting duct carcinoma of the kidney. Hum Pathol. 1990;21:449-456. (Pubitemid 20141032)
29. Rumpelt HJ, Storkel S, Moll R, et al. Bellini duct carcinoma: Further evidence for this rare variant of renal cell carcinoma. Histopathology. 1991;18:115-122.
30. Amin MB, Varma MD, Tickoo SK, et al. Collecting duct carcinoma of the kidney. Adv Anat Pathol. 1997;4:85-94.
31. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol. 1998;15:54-67. (Pubitemid 28093788)
32. Tokuda N, Naito S, Matsuzaki O, et al. Collecting duct (Bellini duct) renal cell carcinoma: A nationwide survey in Japan. J Urol. 2006;176:40-43. (Pubitemid 43815375)
33. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009;22(suppl 2):S2-S23.
34. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: Report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679-684. (Pubitemid 27494985)
35. Amin MB, MacLennan GT, Paraf F, et al. Tubulocystic carcinoma of the kidney: Clinicopathologic analysis of 29 cases of a distinctive rare subtype of renal cell carcinoma (RCC). Lab Invest. 2004;84(suppl 1):137A.
36. Baer SC, Ro JY, Ordonez NG, et al. Sarcomatoid collecting duct carcinoma: A clinicopathologic and immunohistochemical study of five cases. Hum Pathol. 1993;24:1017-1022. (Pubitemid 23281540)
37. Kobayashi N, Matsuzaki O, Shirai S, et al. Collecting duct carcinoma of the kidney: An immunohistochemical evaluation of the use of antibodies for differential diagnosis. Hum Pathol. 2008;39:1350-1359.
38. Polascik TJ, Cairns P, Epstein JI, et al. Molecular genetics and histopathologic features of adult distal nephron tumors. Urology. 2002;60:941-946. (Pubitemid 35447543)
39. Polascik TJ, Cairns P, Epstein JI, et al. Distal nephron renal tumors: Microsatellite allelotype. Cancer Res. 1996;56:1892-1895. (Pubitemid 26118228)
40. Schoenberg M, Cairns P, Brooks JD, et al. Frequent loss of chromosome arms 8p and 13q in collecting duct carcinoma (CDC) of the kidney. Genes Chromosomes Cancer. 1995;12:76-80.
41. Steiner G, Cairns P, Polascik TJ, et al. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: Region of minimal deletion at 1q32.1-32.2. Cancer Res. 1996;56: 5044-5046. (Pubitemid 26374447)
42. Gregori-Romero MA, Morell-Quadreny L, Llombart-Bosch A. Cytogenetic analysis of three primary Bellini duct carcinomas. Genes Chromosomes Cancer. 1996;15:170-172. (Pubitemid 26112509)
43. Wright JL, Risk MC, Hotaling J, et al. Effect of collecting duct histology on renal cell cancer outcome. J Urol. 2009;182: 2595-2599.
44. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1-11.
45. Swartz MA, Karth J, Schneider DT, et al. Renal medullary carcinoma: Clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002;60:1083-1089. (Pubitemid 35447572)
46. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: Rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652. (Pubitemid 351744839)
47. de Jong B, Molenaar IM, Leeuw JA, et al. Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet. 1986;21:165-169. (Pubitemid 16163323)
48. Tomlinson GE, Nisen PD, Timmons CF, et al. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet. 1991;57:11-17.
49. Suijkerbuijk RF, Meloni AM, Sinke RJ, et al. Identification of a yeast artificial chromosome that spans the human papillary renal cell carcinoma-associated t(X;1) breakpoint in Xp11.2. Cancer Genet Cytogenet. 1993;71:164-169. (Pubitemid 24040018)
50. Sidhar SK, Clark J, Gill S, et al. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5:1333-1338. (Pubitemid 26335852)
51. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPLTFE3 gene fusion of alveolar soft part sarcoma: A distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192. (Pubitemid 33704203)
52. Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas: Clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008;32:656-670. (Pubitemid 351600831)
53. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009;15:1170-1176.
54. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: Expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31: 1149-1160. (Pubitemid 47207116)
55. Argani P, Laé M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24:1529-1534. (Pubitemid 46638774)
56. Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: Lack of negative impact due to lymph node spread. Cancer. 2008;112:1607-1616. (Pubitemid 351441175)
57. Argani P, Laé M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29:230-240. (Pubitemid 40170642)
58. Weterman MJ, van Groningen JJ, Jansen A, et al. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins. Oncogene. 2000;19:69-74. (Pubitemid 30066352)
59. Ross H, Argani P. Xp11 translocation renal cell carcinoma. Pathology. 2010;42:369-373.
60. Argani P, Hicks J, De Marzo AM, et al. Xp11 translocation renal cell carcinoma (RCC): Extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34:1295-1303.
61. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in endstage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153. (Pubitemid 43740182)
62. Tickoo SK, Gopalan A. Pathologic features of renal cortical tumors. Urol Clin North Am. 2008;35:551-561.
63. Gobbo S, Eble JN, Maclennan GT, et al. Clear cell papillary renal cell carcinoma: A distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
64. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: A study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34: 1608-1621.
65. Michal M, Hes O, Nemcova J, et al. Renal angiomyoadenomatous tumor: Morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009; 454:89-99.
66. Verine J. Renal angiomyoadenomatous tumor: Morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454:479-480.
67. Michal M, Hes O, Kuroda N, et al. Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma. Virchows Arch. 2009;454:719.
68. Mai KT, Kohler DM, Belanger EC, et al. Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity. Pathology. 2008;40:481-486. (Pubitemid 351950899)
69. Sudarshan S, Linehan WM. Genetic basis of cancer of the kidney. Semin Oncol. 2006;33:544-551. (Pubitemid 44511978)
70. Cohen D, Zhou M. Molecular genetics of familial renal cell carcinoma syndromes. Clin Lab Med. 2005;25:259-277. (Pubitemid 40545819)
71. Stewart L, Glenn GM, Stratton P, et al. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol. 2008;144:1584-1592.
72. Hansel DE, Rini BI. Molecular genetics of hereditary renal cancer: New genes and diagnostic and therapeutic opportunities. Expert Rev Anticancer Ther. 2008;8:895-905.
73. Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31:1578-1585. (Pubitemid 47482473)
74. Parwani AV, Husain AN, Epstein JI, et al. Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation. Hum Pathol. 2001;32:506-512. (Pubitemid 32506521)
75. Eble JN. Mucinous tubular and spindle cell carcinoma and post-neuroblastoma carcinoma: Newly recognised entities in the renal cell carcinoma family. Pathology. 2003;35:499-504. (Pubitemid 38041285)
76. Ferlicot S, Allory Y, Compérat E, et al. Mucinous tubular and spindle cell carcinoma: A report of 15 cases and a review of the literature. Virchows Arch. 2005;447:978-983. (Pubitemid 41719553)
77. Kuroda N, Toi M, Hiroi M, et al. Review of mucinous tubular and spindle cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. Histol Histopathol. 2005;20:221-224. (Pubitemid 40029000)
78. Fine SW, Argani P, DeMarzo AM, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:1554-1560. (Pubitemid 44808791)
79. Dhillon J, Amin MB, Selbs E, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009;33:44-49.
80. Paner GP, Srigley JR, Radhakrishnan A, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: Significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006;30:13-19. (Pubitemid 43740204)
81. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol. 2006;19: 488-493.
82. Brandal P, Lie AK, Bassarova A, et al. Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas. Mod Pathol. 2006;19:186-194. (Pubitemid 43117603)
83. Shen SS, Ro JY, Tamboli P, et al. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol. 2007;11:13-21. (Pubitemid 46107880)
84. Argani P, Netto GJ, Parwani AV. Papillary renal cell carcinoma with low grade spindle cell foci: A mimic of mucinous tubular and spindle cell carcinoma. Am J Surg Pathol. 2008;32:1353-1359.
85. Kuroda N, Tamura M, Taguchi T, et al. Sarcomatoid acquired cystic disease associated renal cell carcinoma. Histol Histopathol. 2008;23:1327-1331.
86. Gronwald J, Baur AS, Holtgreve-Grez H, et al. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization. J Pathol. 1999;187:308-312. (Pubitemid 29064156)
87. Cossu-Rocca P, Eble JN, Zhang S, et al. Acquired cystic disease-associated renal tumors: An immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006; 19:780-787. (Pubitemid 43780447)
88. Pan CC, Chen YJ, Chang LC, et al. Immunohistochemical and molecular genetic profiling of acquired cystic diseaseassociated renal cell carcinoma. Histopathology. 2009; 55:145-153.